Mable (Neurolytic Healthcare)

Health Care, Medical, Neuroscience
Founded in 1/1/19
Oxford, Oxfordshire, United Kingdom
For Profit

About Mable (Neurolytic Healthcare)

Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions. The company delivers digitally and genomically-driven medical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 3250000 USD
  • Last Funding: 3200000 USD (Seed)
  • Funding Status: Seed

Technology Stack

Mable (Neurolytic Healthcare) actively uses None products in their tech stack.

Market Presence

Industries: Health Care, Medical, Neuroscience

Headquarters: Oxford, Oxfordshire, United Kingdom

Leadership

  • Roman Rothaermel - Co-Founder & CEO at mable | Neurolytic Healthcare LinkedIn